News

Electrocardiography Equipment

According to a report released last month by Transparency Market Research, the value of the global cardiovascular monitoring and diagnostic devices market is estimated at $797 million this year and is expected to reach $1.3 billion by 2016.

Wed Dec 14 2011By Lanier Norville

According to a report released last month by Transparency Market Research, the value of the global cardiovascular monitoring and diagnostic devices market is estimated at $797 million this year and is expected to reach $1.3 billion by 2016. That’s a predicted gain of almost 9 percent per year. The ECG monitoring equipment segment will lead that growth, according to the report. That segment comprised 51 percent of the market share in 2010.

Cardiovascular diseases are a leading cause of death globally. In 2008, around 17.3 million people died from cardiovascular diseases, accounting for 30 percent of all deaths recorded that year. An estimated 7.3 million of those were due to coronary heart disease, and 6.2 million were the result of stroke. Low- and middle-income countries are affected most. An estimated 80 percent of cardiovascular disease deaths take place in low- and middle-income countries. By 2030, almost 23.6 million people will die from cardiovascular diseases, Transparency Market Research reports.

As the incidence of cardiovascular diseases rises, so will the demand for devices that monitor and diagnose those diseases. The U.S. represents the largest market in the worldwide cardiovascular disease market, followed by Europe and Japan. This market is comprised of electrocardiograph (ECG) monitoring equipment, ECG stress testing systems, Holter monitoring systems, ECG data monitoring systems, event monitoring systems, cardiovascular monitoring and diagnostic devices and cardiopulmonary stress testing systems.

ECG is by far the largest segment, valued at $410.5 million in 2010 and predicted to grow at a rate of 10.7 percent per year through 2016, according to the report.

GE Healthcare, Philips Healthcare, Nihon Kohden, Cardiac Science Corp (now OptoCircuits) and Schiller AG are the leading companies in the global Cardiovascular Monitoring and Diagnostic devices market, with a combined share of more than 60 percent.

Read more in the December 2011 issue of Medical Dealer Magazine.

 

 

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Please review our Privacy Policy for more details.
I Agree